872624-68-5 Usage
Uses
Used in Organic Synthesis:
2-iodo-4-methyl-5-(trifluoromethyl)benzenamine is used as a reagent for the introduction of fluorine-containing functional groups onto aromatic rings, which is crucial for the development of various organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-iodo-4-methyl-5-(trifluoromethyl)benzenamine is utilized for the synthesis of various drugs and pharmaceutical intermediates, contributing to the creation of new therapeutic agents.
Used in Medicinal Chemistry Research:
2-iodo-4-methyl-5-(trifluoromethyl)benzenamine is studied for its potential anti-cancer and anti-inflammatory properties, making it an important target for further research in medicinal chemistry to develop novel treatments for various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 872624-68-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,2,6,2 and 4 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 872624-68:
(8*8)+(7*7)+(6*2)+(5*6)+(4*2)+(3*4)+(2*6)+(1*8)=195
195 % 10 = 5
So 872624-68-5 is a valid CAS Registry Number.
872624-68-5Relevant articles and documents
DEUTERATED COMPOUNDS AS IMMUNOMODULATORS
-
Paragraph 0146, (2019/05/22)
Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I) including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
-
Page/Page column 41, (2008/06/13)
Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula
COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA
-
Page/Page column 66, (2010/02/15)
Compounds of Formula (I): wherein n, m, p, q, Y, R1 R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.
